Loading clinical trials...
Loading clinical trials...
Proof-of-concept Study of BI 655130 add-on Treatment in Patients With Mild-to-moderately Active Ulcerative Colitis During TNF Inhibitor Therapy
Conditions
Interventions
Spesolimab
Placebo
Locations
16
Denmark
Aalborg Sygehus Syd
Aalborg, Denmark
Sanos Clinic
Herlev, Denmark
Odense University Hospital
Odense, Denmark
Universitätsklinikum Erlangen
Erlangen, Germany
Universitätsklinikum Freiburg
Freiburg im Breisgau, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Start Date
June 7, 2017
Primary Completion Date
March 26, 2020
Completion Date
September 16, 2020
Last Updated
October 16, 2025
NCT06294925
NCT05076175
NCT06359808
NCT06651281
NCT04121806
NCT06065228
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions